Cargando…

Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma

The liver is a metabolic hub characterized by high levels of protein synthesis. Eukaryotic initiation factors, eIFs, control the first phase of translation, initiation. Initiation factors are essential for tumor progression and, since they regulate the translation of specific mRNAs downstream of onc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scagliola, Alessandra, Miluzio, Annarita, Biffo, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002961/ https://www.ncbi.nlm.nih.gov/pubmed/36902316 http://dx.doi.org/10.3390/ijms24054885

Ejemplares similares

Translating the Game: Ribosomes as Active Players
por: Calamita, Piera, et al.
Publicado: (2018)

Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study
por: Scagliola, Alessandra, et al.
Publicado: (2022)

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
por: Scagliola, Alessandra, et al.
Publicado: (2021)

mTOR-dependent translation drives tumor infiltrating CD8(+) effector and CD4(+) Treg cells expansion
por: De Ponte Conti, Benedetta, et al.
Publicado: (2021)

Data on the effects of eIF6 downmodulation on the proportions of innate and adaptive immune system cell subpopulations and on thymocyte maturation
por: Manfrini, Nicola, et al.
Publicado: (2017)

Discovery and Preliminary Characterization of Translational Modulators that Impair the Binding of eIF6 to 60S Ribosomal Subunits
por: Pesce, Elisa, et al.
Publicado: (2020)

Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo
por: Miluzio, Annarita, et al.
Publicado: (2015)

eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription
por: Brina, Daniela, et al.
Publicado: (2015)

Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
por: Miluzio, Annarita, et al.
Publicado: (2022)

Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma
por: Marozin, Sabrina, et al.
Publicado: (2010)

Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis
por: Longo, Fabiana, et al.
Publicado: (2021)

SBDS-Deficient Cells Have an Altered Homeostatic Equilibrium due to Translational Inefficiency Which Explains their Reduced Fitness and Provides a Logical Framework for Intervention
por: Calamita, Piera, et al.
Publicado: (2017)

Role of microRNAs in translation regulation and cancer
por: Oliveto, Stefania, et al.
Publicado: (2017)

TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
por: Todisco, Simona, et al.
Publicado: (2019)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

The Translational Machinery of Human CD4(+) T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling
por: Ricciardi, Sara, et al.
Publicado: (2018)

Cap dependent translation contributes to resistance of myeloma cells to bortezomib
por: Mancino, Marilena, et al.
Publicado: (2013)

Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic
por: Yan, Rong, et al.
Publicado: (2023)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
por: Wu, Qiong, et al.
Publicado: (2010)

SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma
por: Lin, Jing, et al.
Publicado: (2023)

Mechanisms of hepatocellular carcinoma progression
por: Ogunwobi, Olorunseun O, et al.
Publicado: (2019)

Sensitivity of Global Translation to mTOR Inhibition in REN Cells Depends on the Equilibrium between eIF4E and 4E-BP1
por: Grosso, Stefano, et al.
Publicado: (2011)

Metabolic Control of Cardiomyocyte Cell Cycle
por: Menendez-Montes, Ivan, et al.
Publicado: (2023)

Progress in stem cell-derived technologies for hepatocellular carcinoma
por: Aravalli, Rajagopal N
Publicado: (2010)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression
por: Su, Jing-Ran, et al.
Publicado: (2016)

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
por: Tsui, Yu-Man, et al.
Publicado: (2020)

Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2021)

The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective
por: Unfried, Juan Pablo, et al.
Publicado: (2021)

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
por: Jiang, Yu, et al.
Publicado: (2019)

ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
por: Deng, Yuanfei, et al.
Publicado: (2022)

A Mad2-Mediated Translational Regulatory Mechanism Promoting S-Phase Cyclin Synthesis Controls Origin Firing and Survival to Replication Stress
por: Gay, Sophie, et al.
Publicado: (2018)

Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
por: Orabi, Danny, et al.
Publicado: (2021)

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
por: Xia, Peng, et al.
Publicado: (2023)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
por: Tenen, Daniel G, et al.
Publicado: (2020)

Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma
por: Lee, Ho-Yeop, et al.
Publicado: (2021)

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
por: Romualdo, Guilherme Ribeiro, et al.
Publicado: (2021)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tomf79mjdfub0gn04ihjlmce46